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1 Introduction 
In Wren et al. (2017) (1), demand for health care services for each year were 
projected from 2015 to 2030 using the HIPPOCRATES model. To develop these 
projections, activity rates by single year of age and sex across each service in the 
base year of 2015 were calculated. Activity rates were calculated by dividing 
activity volumes by numbers in the relevant age cohort in the population. 
Population projections, as well as assumptions regarding healthy ageing and unmet 
need and demand, were then applied to the activity rates to estimate the projected 
demand for each service by males and females of different ages over the time 
horizon (1). The next phase in the development of the HIPPOCRATES model will 
involve the introduction of costs to the model to allow for the projection of 
expenditure over the time period. This will be accomplished by matching unit costs  
to the age and sex-specific activity of each health care service.  
 
A unit cost relates to the cost required to produce one unit of a good or service. As 
such, unit costs can help put large expenditures into context, thereby facilitating 
the more cost-efficient use of resources (2). In order to develop projections of 
expenditure it will be necessary to know the cost related to services demanded. 
However, for many services that will be costed as part of this exercise, it will be 
necessary to develop bespoke unit costs as, unlike other systems (2), no central 
database of unit costs exists for Irish health and social care services. Ideally, unit 
costs will be disaggregated by age and sex to the same level as the relevant 
measure of activity. However, the unit costs to be developed for the HIPPOCRATES 
projection model will be significantly influenced by the quality of cost data 
available for specific services, which may be quite poor in certain cases. In that 
context, this review will provide an understanding of the alternative approaches to 
unit cost development that have been employed in the literature along with their 
relative advantages and disadvantages. This paper was undertaken as part of the 
ESRI Research Programme in Healthcare Reform, funded by the Department of 
Health. 
 
In general, two broad methodological approaches have been identified to cost 
services. For the purposes of this paper, these will be referred to as a top-down 
approach and a bottom-up approach. Top-down approaches can also be referred 
to as gross costing, while bottom-up approaches encompass microcosting, the 
ingredients approach and patient-level costing. These methodologies are used to 
approach the target unit from opposite levels of aggregation and have significantly 
different data requirement. 
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1.1 The top-down approach 
The top-down approach targets the unit of activity from the highest level of data 
aggregation. In its most rudimentary form, the top-down approach can, for 
example, be used to calculate the average cost per patient using the total 
expenditure and number of patients accessing a service. This effectively assumes 
that all patients cost the same amount. This may not be a major issue for services, 
such as GPs, in which costs may be driven by the number of visits rather than the 
intensity of care received by the different patients in a single visit. However, this 
assumption may be unsuitable for services in which there can be considerable 
variation in the resources used by different patients as part of a single episode of 
care such as an inpatient discharge. This could be problematic for the expenditure 
projections as the impact of changes to costs due to changes in patient 
characteristics would not be captured. 
 
Variation in costs can, however, be captured using more nuanced top-down 
approaches. Generally, this involves the division of patients into groups and 
subgroups. While the creation of groups and subgroups introduces some variation 
in costs, it is important to note that the average unit cost estimated for each group 
is still an average, but of a somewhat more homogenous group of patients. In this 
way, an assumption is made that patients with some shared characteristics, 
beyond simply receiving the same health or social care, cost the same amount. The 
creation of each group or subgroup also increases the number of data points 
required. 
 
1.2 The bottom-up approach 
The bottom-up approach targets the unit of activity from the highest level of data 
disaggregation. At its most basic, the bottom-up approach attaches the 
appropriate cost to each of the component resources. These resources can include 
clinical staff time, non-clinical staff time, equipment and the use of land and 
buildings. Staff costs are often included in a unit cost by multiplying the annual 
salary of the relevant type of staff by the proportion of that staff member’s annual 
work time used to treat the relevant patient. The cost of equipment and buildings, 
on the other hand, are often annuitized over their expected useful life or included 
as depreciation. Bottom-up approaches generally produce more precise unit costs 
than top-down approaches (4). 
 
The precision gained by adding together the costs of each component of care 
makes the bottom-up approach very useful in capturing variations in costs when 
changes are being made to existing services (5). However, the price of this extra 
quality is the extra cost and time needed to gather the data and undertake the 
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necessary calculations (6). Overheads, which may include low cost items, such as 
utilities and non-clinical supplies, or indirect resources used by a patient, such as 
administration, support staff and some capital goods, are also captured using the 
bottom-up approach. It is common for overheads to be included as a percentage 
of staff costs in order to reduce the burden of using the bottom-up approach. This 
can be particularly advantageous in the case of a health care professional, such as 
a community based physiotherapist, who may work fairly independently and not 
as part of a larger cost centre. The availability of these overhead rates from a 
representative sample would reduce the data burden involved in using the bottom-
up approach considerably. 
 
1.3 Advantages and disadvantages of the two approaches 
The bottom-up approach assigns costs to each input of a treatment service. In this 
way, the actual cost of treatments can be calculated. Costs calculated using the 
bottom-up approach are more precise than costs calculated by the top-down 
approach. This extra precision allows for the greater analysis of interpatient 
variations in cost. Similarly, the large number of individual observations of cost is 
more likely to allow for the statistical analysis of cost variation (7). This extra 
precision may be of particular use for health technology assessments, in which 
even small variations in cost inputs can have profound effects on the cost 
effectiveness of interventions (5). These benefits of the bottom-up approach do 
not, however, come without cost. The extra precision is dependent on a greater 
number of data points. The gathering of this extra data can be expensive in terms 
of both time and money. The method is also more complex. With so many data 
points to collect, the possibility of overlooking a cost input can increase. The 
allocation of overheads can also be particularly tricky (7). 
 
The top-down approach is easier to perform than the bottom-up approach. It has 
fewer data requirements, and much of the data are routinely collected for 
accounts and management. As such, research using top-down approaches is less 
demanding in terms of time, knowledge and money. With fewer data points it is 
also less likely that inputs will be missed. On the other hand, the top-down 
approach does not allow for the analysis of interpatient variation and the 
secondary data may need to be validated (7). 
 
2 Overview  
The methods used to calculate unit costs in a health or social care setting by 44 
different studies were investigated. The approaches used and costs included for 
different types of studies internationally and in Ireland are summarised in Table 1, 
as well as in Tables A1 and A2 in the Appendix. Of these studies, four were 
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projection models of health and social care, eight were conducted in an Irish 
setting and 32 were conducted outside of Ireland. Of the four projection models of 
health and social care, three used a top-down approach to estimate unit costs (8-
10), while one used a combination of a bottom-up approach and a top-down 
approach (11). 
 
Of the eight studies conducted in Ireland, one was a guideline for the conduct of 
economic evaluations of health technologies Ireland, six were disease/setting 
specific and one was a health technology assessment. The guideline was produced 
by the Health Information and Quality Authority (HIQA) and includes 
methodological guidance on the calculation of the costs of staff and capital goods 
for economic evaluations in health care in Ireland. The guideline suggested the use 
of a bottom-up approach to estimate the cost of staff and capital goods (12). Four 
of the disease/setting specific studies used a bottom-up approach to estimate unit 
costs (13-16), while one other disease/setting specific study used a mix of a 
bottom-up approach and a top-down approach (17) and another used a top-down 
approach (18). One Health Technology Assessment used a mix of a bottom-up 
approach and a top-down approach to estimate the unit cost of an intervention 
(19). 
 
Of the 32 studies conducted outside of Ireland, 13 were non-disease specific, 13 
were disease/setting specific and six were health technology assessments. Seven 
of the 13 non-disease specific studies used a bottom-up approach to estimate unit 
costs (2, 20-25), while four used a top-down approach (26-29) and two used a 
combination of a bottom-up approach and a top-down approach (30, 31). Eight of 
the 13 disease/setting specific studies used a bottom-up approach to estimate unit 
costs (32-39), while five used a mix of bottom-up approaches and top-down 
approaches (40-44). Four of the six health technology assessments used a bottom-
up approach to estimate unit costs (45-48), while one used a top-down approach 
(49) and one other used a mix of a bottom-up approach and a top-down approach 
(50).  
 
The majority of the Irish studies (62.5%), the international non-disease specific 
studies (54%), the international disease/setting specific studies (62%) and the 
international health technology assessments (67%) either proposed using or used 
a bottom-up approach to estimate unit costs. Only among projection models of 
health and social care was a top-down approach used most regularly (75%). It is 
perhaps unsurprising that the bottom-up approach was most favoured among 
health technology assessments as this is where the benefit of more precise 
estimates may be most acute. By contrast, it may be the case that the greater 
number of data points, and so research time and skill, involved in estimating the 
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bottom-up costs of a wide range of health and social care services may have been 
off-putting for those engaged in non-disease specific and projection modelling 
research. This disadvantage of the bottom-up approach may not have been as 
detrimental to those estimating unit costs in a single disease area. 
 
Of the 44 studies, six referenced the Personal Social Services Research Unit (PSSRU) 
(2) as a source for some of their unit cost estimates or for some or all of their unit 
cost methodology (3, 17, 19, 45, 48, 50). The PSSRU have reported on the unit costs 
of care in the United Kingdom annually since 1992. Curtis and Burns published the 
most recent report in 2017 (2). The unit costs of many health and social services, 
both in the community and in hospital settings are calculated as part of this report. 
 
In addition to the 44 studies investigated in this review of unit costing methods, 51 
further studies sourced some or all unit cost estimates or unit cost estimate 
methodology from the PSSRU1 (2). These studies have not been included in this 
review as they either sourced unit costs from the PSSRU and so did not estimate 
them, or used PSSRU methods that have been directly reviewed. For instance, 
Francois et al. (2008) (51) used PSSRU unit cost estimates for participants in the 
UK, eight other European countries, Canada and South Africa, while Chamberlain 
et al. (2011) (52) adapted PSSRU methods to the United States setting. The former 
may be problematic, as the pattern of resource use across disciplines may differ 
between countries. Indeed, these differences can be partly driven by differences 
in the relative costs of disciplines in these countries (53). As such, unit costs 
calculated in one jurisdiction may not be suitable for use in another. Of the 51 
studies, three were projections of health and social care, three were non-disease 
specific studies, 17 were health technology assessments and 28 were 
disease/setting specific studies. The bulk of these studies took place in the UK. 
 
Faraq et al. (2013) (54) is a systematic review of the unit costs of allied and 
community services used by older people in Australia. Of the studies set in 
Australia, it was found that the cost of private sector services can be as much as 
double that of public sector services, though this does vary somewhat across 
disciplines. Variation was also observed in the unit costs of care in different 
countries. This may be attributable to differences in the societal value attached to 
services in different countries (54). The authors reported that many of the 
international studies included in the review were economic evaluations from the 
United Kingdom and that most of these had used PSSRU estimates (54). 
 
                                                          
1 See footnote 6 for full list of studies that used unit cost estimates or unit cost estimate methodology from the PSSRU. 
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Further research into methods to calculate unit costs is currently underway in 
Europe. The Programme in costing, resource use measurement and outcome 
valuation for use in multi-sectoral national and international health economic 
evaluations (PECUNIA) project began in January 2018 and will run until December 
2020. Researchers from ten universities and institutes across six countries will 
contribute to the project. The aims of the project are to develop standardised, 
harmonised and validated methods for the assessment of costs and outcomes of 
healthcare interventions within and across European countries. This is primarily 
targeted at improving the comparability of cost-effectiveness studies across 
countries (55).
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Table 1: Summary of approaches used and costs included by study type. 
 
Study Type Study Type 
Approach Percentage of Studies Including: 
Bottom-up Mixed Top-down Total Capital Staff Materials Direct Indirect 
Projection Models 0 1 3 4 50 50 50 50 25 
Irish 
Disease/Setting Specific 4 1 1 6 33 100 83 100 50 
Health Technology Assessment 0 1 0 1 100 100 100 100 100 
Guideline 1 0 0 1 100 100 100 100 100 
Total (Irish) 5 2 1 8 - - - - - 
International 
Non-Disease Specific 7 2 4 13 70 85 85 85 77 
Disease/Setting Specific 8 5 0 13 62 100 85 92 62 
Health Technology Assessment 4 1 1 6 33 83 66 83 83 
Total (International) 19 8 5 32 - - - - - 
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3 Projection Models 
Wanless (2002) (8) projected the future trends in health, health care resource use 
and expenditure in the UK. A top-down approach with subgroups was used to 
estimate unit costs. For example, patients admitted with heart disease were 
grouped by sex, decedent/survivor status and age. Each group contained patients 
of the same sex, decedent/survivor status and age cohort. In total, patients were 
sorted into 84 separate groups, though only 42 groups were used to estimate unit 
costs as patients were not separated by sex for this estimation. So, each of 42 
estimated unit costs were attached to two groups of patients, a male group and a 
female group of the same age cohort and decedent/survivor status. The cost per 
patient was calculated by dividing the total cost of inpatient admissions for heart 
disease by the number of patients that were admitted. 
 
The overall cost per patient was then multiplied by the number of patients in each 
of the 42 groups to estimate the total cost of each group. The average cost of each 
group was divided by the average length of stay of each group to estimate the 
average unit cost of each day of treatment for inpatients with heart disease 
disaggregated by age and decedent/survivor status. The unit costs for each group 
were potentially more accurate than the overall average cost that could be 
estimated in a rudimentary fashion. These estimates were still averages, albeit of 
smaller more homogenous groups. Various assumptions were made to calculate 
these average unit costs. These were that costs are spread evenly over the entire 
length of stay, that costs did not differ between males and females and that the 
severity of the disease neither altered cost nor was altered by age. 
 
Harris et al. (2008) (9) is a USA based study which evaluated the Veterans Affairs 
(VA) enrolee health care projection model. The enrolment level, utilization rate and 
unit cost were multiplied together to calculate expenditure for each of 58 medical 
services. An average unit cost was obtained for each health service category by 
age, sex and market. For some health service categories, such as outpatient mental 
health programs, special VA programs and prosthetics, the VA’s Decision Support 
System (DSS) contains unit costs that can be input into the projection model. These 
are bottom-up unit costs. For the majority of health service categories, such as 
inpatient, ambulatory and prescription charges, VA unit costs are estimated based 
on Medicare allowable charges or community billed charges. These are top-down 
unit costs. 
 
To derive a VA unit cost from Medicare allowable charges, the first step is to take 
the national average Medicare charge. The average Medicare charge is adjusted to 
reflect regional differences in unit costs due to cost of living and treatment 
intensity. For a few health service categories a further adjustment to reflect 
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covered benefit is also made. Each of these steps is taken twice; once for a Well 
Managed estimate and again for a Loosely Managed estimate. Well Managed and 
Loosely Managed refer to the efficiency of clinical management of different health 
plans. These two estimates are combined using the Degree of Community 
Management (DoCM) percentage. For example if the DoCM percentage is 22 per 
cent, then the combined estimate would be the summation of 22 per cent of the 
Well Managed estimate and 78 per cent of the Loosely Managed estimate. The 
combined estimate is then adjusted for age and gender to give the base unit cost. 
 
Wittenberg et al. (2008) (11) projected the demand for social care for older people 
in England from 2005 to 2041. The authors derived all of the relevant unit costs 
from Personal Social Services (PSS) expenditure (EX1)2 data. The average unit cost 
of each social care service was calculated by dividing the gross expenditure of each 
social care service by the number of recipients of each service. 
 
Leung et al. (2007) (10) projected Hong Kong’s health spending to 2033. Activity 
level data, derived from the Thematic Household Survey 2002, were obtained from 
the Hospital Authority and Department of Health. Unit costs were obtained from 
Hong Kong’s domestic health accounts (57). It appears that the costs of each health 
care sector were calculated using a top-down approach3. The average unit cost of 
each health care sector was then calculated by dividing the total expenditure of 
each health care sector by the level of activity in each sector. 
 
4 The Irish unit cost literature4 
HIQA  (2018) (12) includes methodological guidance on the calculation of the costs 
of staff and capital goods for economic evaluations in health care in Ireland. It is 
recommended that yearly depreciation of buildings, modular buildings, computers 
and ICT systems, other equipment and motor vehicles is included in the cost of care 
until the good is either disposed of or fully depreciated. The rate of depreciation 
ranges from 2.5 per cent per annum to 33.33 per cent per annum in a straight line 
basis, depending on the type of good. The report also notes that the cost of 
equipment maintenance should be included each year. For labour costs, the report 
proposes that the midpoint of the Department of Health’s consolidated salary 
scales for public sector employees should be used. The midpoint salary should then 
be supplemented with superannuation of 4 per cent of direct salary costs, the 
                                                          
2 PSS EX1 was completed annually by 150 councils that had Social Services Responsibilities in the UK (56). 
3 No detail is provided as to how the unit costs were calculated. However, the domestic health accounts only provide 
expenditure at the sectoral level. 
4 Tilson et al. (2007) (58) undertook a cost-effectiveness analysis of hepatitis B vaccination strategies in Ireland. However, 
supplementary data containing information on the methodology and sources used to calculate unit costs were not 
available. 
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employer’s contribution to PRSI and overheads as set out in the revised Regulatory 
Impact analysis guidelines (59). It is advised that overheads should be included at 
a rate of 25 per cent of direct salary costs if no more specific data are available. 
 
Connolly et al. (2015) (15) conducted a study to calculate the resource use and cost 
of patients with amyotrophic lateral sclerosis (ALS). There was one 
multidisciplinary clinic in Ireland, to which each ALS patient had access. To gather 
the resource use data necessary to use the bottom-up approach, a retrospective 
review of 119 charts as well as 17 telephone surveys of primary care givers were 
undertaken. Numerous sources were used to estimate the appropriate cost 
associated with each resource used. These sources included Department of Health 
salary scales, Health Service Executive (HSE) for outpatient attendances and 
accident and emergency admissions, Healthcare Pricing Office (HPO) Hospital In-
Patient Enquiry (HIPE) scheme1 for inpatient discharges, the Primary Care 
Reimbursement Service (PCRS) and the MIMS Ireland catalogue for medications 
and the Irish Motor Neuron Disease Association for aids and appliances. The unit 
cost of treating patients with ALS was estimated by multiplying the unit cost of 
each resource used by the number of resources used. 
 
Gillespie et al. (2011) (14) examined the cost of gestational diabetes mellitus 
(GDM) in Ireland. The authors used a bottom-up approach. The costs of screening, 
testing and treatment of GDM were calculated. Staff time, consultations, 
equipment and medication were incorporated into the unit costs. Data on resource 
use were sourced within Ireland where possible and from the United Kingdom 
where it was not. Administration and the oral glucose tolerance test resource use 
were collected within the study. The number of diabetic specialist nurse 
consultations, dietician consultations as well as the number of lancets, testing 
strips and blood glucose meters were assumed. The dose of medications were 
obtained from the National Institute of Clinical Excellence. Consultants provided 
information as to the resource usage of women with and without GDM. 
 
Data on the costs of the resources used were sourced within Ireland where possible 
and from the United Kingdom where it was not. Administration costs were 
obtained from a telecommunications provider and a job advertiser. The costs 
associated with the oral glucose tolerance test was sourced from ATLANTIC 
Diabetes in Pregnancy and the Department of Health and Children. The cost of 
consultations was also supplied by the Department of Health and Children. The 
cost of medication was taken from the MIMS Ireland catalogue. The costs of 
delivery and neonatal care were sourced from the Department of Health and 
Children. The unit cost of detecting and treating GDM was estimated by applying 
the unit cost of each resource used by the relevant women. 
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O’Sullivan et al. (2016) (18) conducted an analysis of the costs of implementing 
advanced care planning for nursing home residents using a top-down approach. 
This analysis was conducted on the back of a clinical trial. The probability of 
residents in three nursing homes being admitted as a hospital inpatient before and 
after the intervention ‘Let Me Decide’ was implemented. It was assumed that 
residents would be transferred by ambulance. The costs associated with an 
inpatient stay for different DRGs was sourced from the 2013 version of the ready 
reckoner. These were used to form an average cost per episode. The cost 
associated with an ambulance transfer, sourced from Gannon et al. (2007) (60), 
was then added to the average cost of hospitalisation to calculate the unit cost of 
hospital admission from a nursing home. The change in the probability of a hospital 
admission and the average cost per case obtained from the three nursing homes 
were then applied to the population of nursing home residents in Ireland. This 
implies that the three nursing homes were a representative sample of all nursing 
homes in Ireland. 
 
Hanly et al. (2015) (13) estimated the direct costs of radiotherapy for rectal cancer 
using a bottom-up approach. Resource use was obtained through interviews with 
management and clinical staff and onsite observation of treatments. The purchase 
price of equipment was obtained either from two hospitals or from Kesteloot et al. 
(2000) (61).The cost of repair and maintenance of equipment was obtained from 
the hospitals. Resources were categorized into the cost of labour, capital, 
consumables and overheads. The costs of labour and overheads were calculated in 
accordance with guidelines set out in HIQA (2014) (62), while building costs were 
not included in the analysis. Capital costs were annuitized over their expected life 
and equipment was assumed to have a discount rate of 4 per cent. The cost of 
equipment was assigned to patients on a per minute basis. The unit cost of 
radiotherapy for patients with rectal cancer was then estimated by multiplying the 
unit cost of each resource by the number of each resources utilised. 
 
Butler et al. (2016) (16) examined the cost of frailty in people with cognitive 
impairment. The study calculated formal health and social care costs and informal 
caregiving costs using a bottom-up approach. Formal health and social care activity 
included, but was not limited, to inpatient visits, accident and emergency visits, 
outpatient consultations and general practice visits. Resource use was collected 
over a six-month period. The unit costs of resources were obtained from Irish data 
sources including the HPO HIPE scheme and salary scales from the Department of 
Health and Children. Informal caregiving activity included hours dedicated to 
activities of daily living and supervision. For employed caregivers, the cost was one 
hour of the average industrial wage, while for unemployed caregivers, the cost was 
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25 per cent of the average industrial wage. The unit cost of health and formal care 
was estimated by multiplying resource use by the unit cost of each resource, before 
summing the resultant costs per resource. The unit cost of informal care was 
estimated by multiplying hours of informal care by the appropriate cost per hour. 
 
Manca et al. (2003) (19) undertook a cost-utility analysis of tension free vaginal 
tape versus colposuspension across 14 centres, 13 in the United Kingdom and one, 
the National Maternity Hospital, in Ireland. The analysis was part of a trial, during 
which resource use was recorded. Estimates of the unit cost of the resources used 
were gathered from United Kingdom sources. These included the Personal Social 
Services Research Unit (PSSRU), review bodies for nurses and doctors, the 
Chartered Institute of Public Finance and Accountancy and Sculpher (1996) (63). 
The unit costs were estimated using a mixture of the bottom-up and top-down 
approaches. For instance, the unit cost of staff was calculated using a bottom-up 
approach by applying overheads to the midpoint on the relevant salary scale. The 
unit cost of staying on a ward, on the other hand, was calculated using a top-down 
approach by adding the average hospital ward and general service cost per 
inpatient day estimated by a hospital. The unit cost of outpatient care was assumed 
to be the same as the cost of staying on a ward. The unit cost of each arm of the 
model was then estimated by multiplying unit cost of each resource by the number 
of each resource used by each arm of the model. 
 
Brick et al. (2015) (17) performed an economic evaluation of palliative care in 
Ireland using a bottom-up approach where possible and a top-down approach 
otherwise. Resource use data were obtained from HIPE and other decedent 
healthcare records, key informants and nurse time-use diaries from community 
specialist palliative care teams. A wide range of Irish sources were used to gather 
cost data. These sources included the HSE, the PCRS, the Central Statistics Office, 
the National Consumer Agency and the Irish Cancer Society. The unit costs of allied 
health staff were calculated, using a bottom-up approach, by adapting the PSSRU 
method to the Irish setting. Two unit costs were calculated for GPs using a top-
down approach, one for medical cardholders and another for non-medical 
cardholders. For medical cardholders, the average payment to GPs per medical 
cardholder was divided by the average number of GP visits per medical cardholder, 
while, the average cost of a GP visit for a non-medical cardholder was obtained via 
an independent price survey. The unit costs of dentists, formal community care, 
hospital costs, day care, nursing homes, hospice, prescription drugs, meals-on-
wheels, equipment, home modifications and informal care were also calculated. 
The unit costs for formal and informal care per patient in the last year of life was 
estimated by multiplying the unit cost of resources by the patient’s utilisation of 
said resources. 
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5 The International unit cost literature 
5.1 Non-disease specific 
Curtis and Burns (2017) (2) is the most recent in a series of annual reports on the 
unit costs of care in the United Kingdom, that has been published by the PSSRU 
since 1992. The unit costs of many health and social services, both in the 
community and in hospital settings are calculated in this report. The unit costs and 
the methods used to estimate them are extensively cited in the literature5, 
particularly in the United Kingdom. The framework used by the PSSRU to calculate 
the unit costs of staff differs somewhat from the framework used to calculate the 
unit costs of services. The framework used to calculate the unit costs of a 
community based occupational therapist and the framework used to calculate the 
unit cost of a place in a Care home for people requiring long-term mental health 
support will be used to exemplify this point. 
 
For an Occupational therapist, the starting point for the bottom-up calculation of 
the unit cost of health care staff begins with the mean full time salary. The 
employer’s national insurance contribution and the employer’s contribution 
towards superannuation of 17 per cent of the basic salary are added. This is the 
direct care salary. The qualification costs associated with an Occupational therapist 
are then added. The qualification costs are a function of the costs of tuition, 
infrastructure, clinical placement, lost productivity during training and the 
expected working life of the profession. After this, three forms of overheads are 
added: 
1) Direct overheads, amounting to 29 per cent of the direct care salary, 
cover management, administration and utilities. 
2) Indirect overheads, calculated as 16 per cent of the direct care salary, 
cover general management and support services. These overheads are 
based on the accounts of ten community trusts6. 
3) Capital overheads, including building facilities are annuitized over 60 
years with a 3.5 per cent discount rate. 
A location multiplier is then applied to the total yearly cost to account for 
differences in cost inside and outside of London. The total yearly cost is divided by 
time worked per year to give the unit cost per period of time of an Occupational 
therapist. 
 
                                                          
5 Studies that used PSSRU calculations or methods for some or all unit costs (3, 17, 19, 45, 48, 50-53, 64-111)  
6 Community trusts are the bodies that deliver community care in the UK. 
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For a place in a Care home for people requiring long-term mental health support, 
the starting point of the unit cost estimate is the cost of buildings. Capital costs are 
annuitized over 60 years, with a 3.5 per cent discount rate for the first 30 years and 
a 3 per cent discount rate for the second 30 years. To this, the median weekly cost 
estimate of the Adult Social Care Finance Return for adults aged 18-64 who are in 
need of long-term mental health support, is added. Finally, a personal allowance, 
as calculated by the Department of Work and Pensions, is added. The method of 
calculating this unit cost more closely resembles a top-down approach than does 
the PSSRU unit cost methodology for staff seen above. 
 
Riewpaiboon et al. (2011) (22) is a cost analysis of the reimbursement of 
pharmaceutical services in hospitals in Thailand. Costs were calculated using a 
bottom-up approach. The cost of construction, buildings, furniture, equipment and 
vehicles were included as capital costs with a discount rate of 3 per cent. The useful 
lifespan of equipment and buildings were five and 25 years respectively. Staff costs 
included salaries, administrative payments and overtime. Overheads, at a rate of 
20 per cent of the direct pharmacy costs, were included to represent the cost of 
capital, staff and materials from supporting staff. Unit costs were calculated using 
a bottom-up approach by applying the cost of pharmaceutical items to the 
pharmaceutical use of patients. The unit costs of different hospital settings were 
calculated by tracking the resource use of patients and multiplying the amount of 
each resource used by the unit cost of said resource. As such, there are separate 
unit costs for regional hospitals, general hospitals, ambulatory settings, inpatient 
settings, specific pharmaceuticals and each combination thereof.  
 
Younis et al. (2010) (25) studied the determinants of hospital costs in Palestine. 
Capital and staff costs were calculated using a bottom-up approach for each 
hospital department. The cost of drugs, laboratories and consumables were 
assigned to each department based on their actual distribution. Other overheads 
were assigned to departments, using a top-down approach, based on the relative 
weight of their direct costs. The average unit cost of each department was 
estimated by dividing the total expenditure of each department by the number of 
admissions to that department. 
 
Younis et al. (2013) (24) estimated the cost of public hospitals and primary health 
care centres in Palestine. All operational costs were assigned to individual 
departments in hospitals and primary health care centres. Operational costs 
included the cost of staff, pharmaceuticals and supplies. Capital costs were not 
included in the analysis. Each department was categorised as being an overhead, 
intermediary or final department. The costs of overhead departments were 
allocated to intermediary and final departments using the step down allocation 
15 
 
method. The average unit cost of each intermediary and final department was then 
estimated by dividing the total departmental expenditure by the number of patient 
visits to that department. 
 
Ylijoki-Sørensen et al. (2014) (23) studied the costs associated with cause of death 
investigations in Finland and Denmark. The costs were calculated using a bottom-
up approach. This study produced unit costs for both forensic and medical 
autopsies in Finland and Denmark. The cost of medical autopsies included the costs 
of staff, buildings, equipment, morgue costs and the transport of cadavers in both 
jurisdictions. The cost of forensic autopsies included these same costs as well as 
the costs of additional investigations, forensic chemistry and trainee forensic 
examiners. The cost of forensic examiners was also included in Denmark but not in 
Finland. In all cases, the average unit cost was calculated by dividing the total 
expenditure on autopsies in each country by the number of autopsies in each 
country. 
 
Hariharan (2015) (26) estimated the cost involved in the running of four operating 
rooms in a hospital in the West Indies per day. A top-down cost block approach 
was used to calculate the costs involved in running the operating rooms. This 
method involved categorising the costs into six baskets. These were: capital costs, 
estate costs, the cost of nonclinical support services, the cost of clinical support 
services, the cost of consumables and staff costs. Capital costs mainly included the 
costs of various items of medical equipment, depreciated at a rate of 10 per cent 
since purchase. Estate costs included the costs of utilities, sterilization services, 
laundry and ventilation. The costs of nonclinical support services were made up of 
salaries for non-medical staff. The costs of clinical support staff comprised the costs 
of medical staff with the exception of consultants, surgeons and anaesthetists. The 
cost of consumables included the costs of disposable and single use equipment and 
anaesthetics. Finally, staff costs were made up of the salaries of consultants, 
surgeons and anaesthetists. The average unit cost of running four operating rooms 
was calculated by dividing the annual costs associated with running the four 
operating rooms by the number of days in the year. This was then divided by the 
number of operating rooms (four) to give the average unit cost per day associated 
with running an operating room. 
 
Javid et al. (2016) (30) compared activity-based costing with traditional cost 
systems for calculating the unit costs of medical services in a hospital in Iran. To 
use the activity based costing method, the hospital was split into patient care cost 
centres and supportive cost centres. The direct cost of each cost centre was 
calculated, using a bottom-up approach, by summing all of the capital, staff and 
material costs associated with each cost centre. Where staff worked in more than 
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one cost centre, their cost was apportioned according to their workload in the 
different centres. Capital costs included the straight line discounted depreciation 
of buildings, vehicles, equipment and furniture. The direct costs associated with 
supportive cost centres were allocated to patient care cost centres according to 
resource cost drivers. 
 
These cost drivers were: personnel workload, quantity of equipment, floor area, 
and estimation. The costs associated with each patient care cost centre was then 
apportioned to specific activities, using a top-down approach. Resource use for 
each activity was determined through structured interviews with the involved 
people7. The average unit cost per bed day was calculated by summing the cost of 
each activity and dividing by the number of patients availing of each activity. For a 
number of medical services, the estimated unit costs were lower when calculated 
by the traditional cost system as compared to activity-based costing. This 
difference was statistically significant at the 99 per cent level of significance for 
laboratory services, ophthalmology services, pharmacy services and surgical unit 
services. The total unit cost was also lower when calculated by the traditional cost 
system rather than activity based costing. 
 
Mann (1999) (28) estimated the unit cost of consumables in an intensive care unit 
in New Zealand. The annual fixed cost of consumables that could not ordinarily be 
assigned individually, such as stationary, disposable cups and hand towels, were 
combined. The average unit cost of consumables per patient hour was estimate by 
dividing the total annual cost of consumables by the annual number of patient 
hours in the intensive care unit. 
 
Mark et al. (2009) (20) investigated the relationship between nursing working 
conditions and nursing unit costs. The analysis was conducted across 210 nursing 
units in the USA and used a bottom-up approach. The cost of nursing incorporated 
the cost of salaries, fringe benefits and overtime of registered nurses, licensed 
practical nurses, unlicensed personnel permanently assigned to a unit and 
supplemental nurses on a unit over a six-month period. The analysis did not include 
fixed costs, supply costs nor capital costs. The salaries were adjusted for regional 
variation using the Centers for Medicare and Medicaid Services (CMMS) wage 
index. The average unit cost of nursing per patient day was estimated by dividing 
the total salary costs by the number of patient days reported in the same nursing 
units over the same six-month period. 
 
                                                          
7 It is unclear whether the involved people were members of staff, patients or both. 
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Minh et al. (2010) (29) estimated the cost of clinical services in rural district 
hospitals in Vietnam using a top-down approach. Capital costs, operating costs and 
staff costs were included in this analysis. Capital costs included straight line 
depreciation of buildings, vehicles and equipment. Operational costs included 
utilities, travel expenses, training, maintenance and non-clinical supplies. Each of 
these costs was included in the cost of each hospital department. The departments 
were then organised into direct cost centres and indirect cost centres. Direct cost 
centres provided services directly to patients while indirect cost centres supplied 
services to other cost centres. The costs of indirect cost centres were allocated to 
direct cost centres using the step down approach, until all costs were part of cost 
centres delivering services directly to patients. Costs were allocated from indirect 
cost centres to direct cost centres using four cost drivers; floor space of direct cost 
centres, direct costs of final cost centres, the costs of staff associated with direct 
cost centres and the number of bed days associated with direct cost centres. The 
average unit cost was then estimated by dividing the total cost of each direct cost 
centre by a relevant form of patient interaction, such as visits or bed days. 
 
Oostenbrink et al. (2003) (21) estimated the cost of inpatient hospital days in the 
Netherlands. Capital costs, staff costs, the cost of consumables and overheads 
were all included in the analysis. Nursing costs included wages, fees for irregular 
hours, social premiums and the cost of replacement during illness. The average 
unit cost of nursing per inpatient day was estimated by dividing annual nursing 
department costs by the number of inpatient bed days. The average unit costs of 
specialists and residents who were directly employed by the hospital were 
calculated in the same manner. Self-employed specialists and residents provided 
an estimate of the amount of time per day spent with a single inpatient. This time 
estimate was multiplied by the average salary of specialists and residents to 
calculate an annual unit cost. Indirect costs, such as equipment and overheads, 
were allocated to final cost centres based on weightings of relevant cost drivers 
such as amount of floor space, number of bed days or number of full time 
equivalents. The average unit cost of these indirect costs was then estimated by 
dividing indirect costs in each final cost centre by the number of inpatient days in 
each final cost centre. The average unit cost of each final cost centre was then 
estimated by summing these component unit costs. 
 
Ramiarina et al. (2007) (31) estimated hospital costs as a function of patient and 
admission characteristics in Brazil. All of the hospital’s costs were assigned to one 
of three centres: the auxiliary diagnostic and treatment centre, the support and 
administration centre or the expense generator centre. The expense generator 
centre contained costs directly related to ambulatory care, clinics and surgery. The 
cost of maintenance, management and transport are a few examples of the costs 
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included in the support and administration centre. The auxiliary diagnostic and 
treatment centre included all imaging costs, the cost of laboratories and the cost 
of blood banks. The costs associated with the support and administration centre 
and the auxiliary diagnostic and treatment centre were allocated to services in the 
expenses generator centre according to a weighting based on the number of 
patients per day in each service in the expenses generator centre. The average unit 
cost per patient day was estimated by dividing the total expenditure associated 
with each service in the expenses generator centre by the number of patient days 
in each centre. The average inpatient unit cost was then calculated by multiplying 
the average unit cost of a patient day in the relevant service by the length of stay 
of each patient. 
 
Chatterjee et al. (2013) (27) estimated the unit costs of different medical services 
in India. The costs were estimated using a top-down approach. Hospital 
departments were divided into two categories – departments that directly 
provided care to patients, i.e., patient care cost centres, and departments that 
supplied direct support to patient care cost centres, i.e., supportive cost centres. 
Patient care cost centres included the outpatient department, the inpatient 
department and the operating theatre, while supportive cost centres included the 
administration department, the laundry department, the kitchen and the transport 
department. The direct costs of each cost centre were calculated by summing the 
cost of staff, capital costs and the cost of materials. Capital costs included the 
annualised discounted depreciation of building, vehicles, equipment, and furniture 
and the opportunity cost of land. The useful life of buildings and structure was 
considered 20 years, while the useful life of other capital items was assumed five 
years. A 3 percent discount rate was applied to all capital costs. Staff costs included 
salaries and fringe benefits. Where staff worked in more than one cost centre, the 
cost associated with that member of staff was allocated to each cost centre 
according to the proportion of time spent working in each cost centre. 
 
The costs of supportive cost centres were allocated to patient care cost centres 
using the simultaneous equation method. These costs were allocated according to 
cost drivers of patient care cost centres, such as floor area or staff full time 
equivalents. These were then known as the indirect costs of patient care cost 
centres. The full cost of each patient care cost centre was estimated by summing 
all relevant direct and indirect costs. The average unit cost of each patient cost 
centre was estimated by dividing the total cost of each patient cost centre by a 
relevant output, such as patient visits or patient bed days.  
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5.2 Disease/Setting specific 
Beck et al. (1999) (32) compared the cost of paediatric HIV hospital provision as 
estimated by hospital prices with estimates obtained through a research based 
costing exercise in the UK. Unit costs for outpatient visits, inpatient days, tests, 
procedures and pharmaceuticals were estimated using a bottom-up approach. The 
cost of outpatient visits and inpatient days included the costs of staff time allocated 
to HIV related duties, overheads that incorporated other general staff, 
miscellaneous expenditure, overheads and central support services. The cost of 
tests included the sum of money transferred between departments in hospitals as 
well as additional department costs and overheads, central support services costs 
and the cost of infection control. The cost of surgical procedures included the cost 
per operating hour and overheads combined with the duration of typical 
procedures. Pharmaceutical costs included the price of all drugs used by children 
with HIV combined with the average daily dose of each medication. The average 
unit cost of inpatients, outpatients, tests, surgeries and medications were 
calculated by dividing the relevant total expenditure by the number of inpatient 
days, outpatient visits, tests performed, surgical procedures performed or the 
number of doses of pharmaceuticals taken. 
 
Zulu et al. (2017) (39) studied cost and utilisation patterns of a pilot sign language 
interpreter service in the primary care setting in a number of regions of South 
Africa. Costs were calculated using a bottom-up approach. Capital and recurring 
costs were recorded as part of the project. The cost of training an interpreter, office 
space, furniture and equipment were included as capital costs. Furniture and 
equipment were assumed to have a useful lifespan of 10 and five years 
respectively. Staff costs, utilities, consumables and transport were included as 
recurrent costs. Overheads included the cost of the proportion of buildings used 
for project purposes. The average unit cost was calculated by dividing total 
expenditure by the number of people who used an interpreter. As such, the unit 
costs reflect an average cost across different ages, genders and regions in South 
Africa. 
 
Groessl et al. (2009) (35) conducted a cost analysis of physical activity intervention 
for older people in the USA. The cost of the intervention was calculated using a 
bottom-up approach. The number of intervention sessions per group of 
participants as well as the amount of time needed for each staff member to provide 
a session were recorded. Similarly, the number of participants in each group and 
their attendance at sessions were recorded. Facilities and indirect costs were 
included as a percentage of health care staff costs. Expenditure on exercise 
equipment and all other materials used as part of the intervention was also 
recorded. The total cost of the intervention was then divided by the number of 
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intervention participants to estimate the average unit cost of the intervention per 
participant. So, although the cost of the intervention was calculated using a 
bottom-up approach, the unit cost was derived on average. This does not affect 
the precision of the unit cost estimate with respect to the entire intervention 
group. However, it does make it impossible to distinguish between the unit cost of 
different subgroups of the participants. 
 
Tianviwat et al. (2009) (43) estimated the unit cost of dental services in institutional 
and community settings in Thailand. The costs were estimated using a mix of the 
bottom-up and top-down approaches. Hospital departments were divided into two 
categories – departments that directly provided dental care to patients, i.e., service 
cost centres, and departments that supplied direct support to service cost centres, 
i.e., supporting cost centres. Service cost centres consisted of the outpatient 
department, the emergency department, the dental department, the primary care 
unit, the Thai traditional medicine department, and the inpatient department. 
While supporting cost centres consisted of administration, supplies, registration, 
nursing, pharmacy, laboratory, x-ray, and delivery room. The costs of capital 
depreciation, materials and staff were included in the costs of each cost centre 
using a bottom-up approach. 
 
The cost associated with supporting cost centres were allocated to service cost 
centres, using a top-down approach, according to weightings of key cost drivers, 
such as the proportion of administration time devoted to dental activities or the 
number of autoclaves provided to the dental unit. Direct and indirect costs 
associated with dental service cost centres were then apportioned to specific 
dental activities. These costs were assigned based on interviews with dentists and 
dental nurses. The cost of staff was allocated to these dental activities according 
to the time requirements of each activity. The cost of materials were allocated to 
activities according to the number of units required for the activities. The average 
unit cost was then estimated by dividing the total cost of each activity by the 
number of patients that used said activity. 
 
Wanitphakdeedecha et al. (2010) (38) estimated the unit cost of a Mohs8 and 
Dermasurgery unit in Texas, USA. The costs were calculated using a bottom-up 
approach. Direct and indirect costs contributed to the total cost of the unit. Direct 
costs consisted of capital costs, staff costs and the cost of materials. The cost of 
staff was the single largest driver of costs. The average amount of time spent at 
the unit and the amount of time spent on each procedure by surgeons was 
obtained through interviews with the surgeons. The annual cost of Mohs surgeons 
                                                          
8 A type of microscopically controlled surgery 
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was estimated by multiplying estimated time working in the unit by the average 
income of a surgeon. It was assumed that nursing and support staff worked at the 
unit for the same proportion of the year as the surgeons. As such, the costs of 
nurses and support staff were estimated in a similar manner as the mohs surgeons. 
Indirect costs include overheads and administration costs. The average unit cost of 
each service and medical procedure was estimated by dividing the cost of each 
service or procedure by the number of services or procedures. 
 
Chatterjee et al. (2011) (41) examined the economic burden of diabetes in 
Thailand. As part of this study, the authors estimated the unit cost of medical 
services at Waritchaphum hospital. The costs were calculated using a mix of the 
bottom-up and top-down approaches. Each of the departments in the hospital was 
classified as either a patient care cost centre or a supporting cost centre. The direct 
costs of each cost centre were calculated, using a bottom-up approach, by 
summing the costs of capital, staff and materials with which it was associated. The 
direct costs of the supporting cost centres were than allocated to the patient care 
cost centres, using a top-down approach, using the simultaneous equation 
approach. The average unit cost of inpatient stay per day, outpatient per visit and 
pharmacy per prescription was estimated by dividing the total cost of each cost 
centre by the relevant unit of activity, i.e., bed day, visit or prescription. 
 
Chou et al. (2007) (33) studied the costs associated with adverse event procedures 
for an International clinical trial. Costs were calculated using a bottom-up 
approach. The costs included the cost of personnel, pharmacy costs, the cost of 
patient care, laboratory costs and the cost of equipment. Time and motion studies 
and interviews with staff were used to estimate the proportion of staff time 
dedicated to adverse event procedures. For the cost of personnel, this proportion 
was multiplied by annual salary to estimate the cost of staff. The patient care costs 
associated with adverse events were estimated as a proportion of total patient 
care costs, using the same proportion as the proportion of unscheduled visits 
compared to all study visits. Laboratory costs were captured as contractual fees. 
Pharmacy costs reflect actual expenses billed to the study. The costs of equipment 
were apportioned according to the proportion of personnel time spent on adverse 
events. The average unit cost per adverse event was calculated by dividing the total 
expenditure associated with adverse events by the number of adverse events. 
 
Dalaba et al. (2013) (42) examined the cost of maternity services in the primary 
care setting in Ghana. A mix of the bottom-up and top-down approaches was used 
to calculate the costs. Departments were categorised into three cost centres. 
These were the direct cost centre, the intermediary cost centre and the indirect 
cost centre. The direct cost centre included costs directly associated with antenatal 
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care, delivery care and family planning. The intermediary cost centre included the 
costs of diagnostic and departmental support. The indirect cost centre included the 
costs of services that were provided only to other departments and not patients. 
Recurrent costs – consisting of personnel costs, administrative costs, pharmacy 
costs, laboratory costs and the cost of medical supplies – were assigned as 
appropriate to each cost centre using a bottom-up approach. Personnel costs 
included overtime, housing allowances and training costs. Administrative costs 
included utilities, maintenance costs and transport costs.  
 
Capital costs – consisting of the cost of buildings, the cost of vehicles and the cost 
of equipment – were also included for relevant cost centres. A discount rate of 3 
per cent was applied to all capital costs. The cost of equipment was annuitized over 
a 10-year useful lifespan, while the cost of buildings was annuitized over a 30-year 
useful lifespan. All costs from the intermediary cost centre and the indirect cost 
centre were allocated to the direct cost centre, using a top-down approach. Finally, 
the average unit cost of each cost centre was estimated by dividing the total cost 
of each cost centre by the relevant output of each cost centre. 
 
Davies et al. (2011) (40) studied the effects of pre-clinical group education sessions 
and system redesign on pain medicine units and patient outcomes in Australia. The 
average unit cost of the pain management unit per new patient was estimated by 
dividing the total salary costs of staff by the number of new patients offered an 
appointment. Capital expenses, the costs of goods and services, and the cost of 
office and clinic space were excluded from the analysis. 
 
Demarré et al. (2015) (34) evaluated the cost of pressure ulcer prevention and 
treatment in nursing homes and hospitals in Belgium. The costs were calculated 
using a bottom-up approach. The cost of pressure ulcer prevention consists of the 
material cost per day and the labour cost per day for each patient. The material 
cost per day consists of the sum of all of the unit costs of materials used by each 
patient, while the labour cost per day is made up of the nursing labour cost per 
activity multiplied by the frequency of the activity per day. The unit cost of the 
prevention of pressure ulcers per patient per day was estimated by adding the unit 
cost per day per patient of pressure ulcer preventing devices and the unit cost of 
labour to provide prevention of pressure ulcers per day. The average unit cost of 
prevention per patient was then estimated by summing each patient’s unit cost 
and dividing by the number of patients. The unit cost of the treatment of pressure 
ulcers in Belgium was calculated in a similar manner. 
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Villarreal Ríos et al. (2006) (44) examined the cost of caring for a diabetic patient 
with hypertension in the primary care setting in Mexico. Total costs were divided 
into fixed costs and variable costs. For variable unit costs, a group of experts 
advised the authors as to the types and amounts of activities that should be 
included. The amount of resources required for these activities was multiplied by 
the unit cost of each resource. The costs of the resources of all activities were 
added together to estimate, using a bottom-up approach, the variable unit cost. 
 
For fixed costs, departments were classified as either intermediary departments or 
final departments. The cost of equipment, the cost of consumables, the cost of 
staff and the cost of capital were included in both types of departments, using a 
bottom-up approach. The costs associated with the intermediary departments 
were allocated to final departments, using a top-down approach, in proportion to 
the weighting of the final departments with respect to cost drivers. For instance, 
the final department that needs the most floor space might receive the highest 
proportion of furniture costs from intermediary departments. The fixed unit cost 
was estimated, using a top-down approach, when all of the costs associated with 
intermediary departments had been reallocated to final departments. The unit 
cost by reason of care was estimated by summing the fixed and variable unit costs. 
 
Kamolratanakul et al. (2002) (36) examined the cost different types of tuberculosis 
patient at tuberculosis centres in Thailand. The costs were estimated using a mix 
of bottom-up and top-down approaches. Five cost centres were identified. These 
were treatment units, radiology units, laboratory units, pharmaceutical units and 
administration and support units. The direct costs of each unit were calculated, 
using a bottom-up approach, by summing the cost of staff, materials and capital 
for each unit. The costs of the administration and support unit were then allocated 
to the four other cost centres, using a top-down approach, using the simultaneous 
equation method, modified by appropriate criteria. The unit cost of each of the 
four other cost centres was then calculated by dividing the total cost of each cost 
centre by an appropriate output. 
 
Kim et al. (2015) (37) studied the cost of adult voluntary male circumcision. The 
costs were calculated using a bottom-up approach. Costs were divided into direct 
costs and indirect costs. Direct costs consisted of the cost of consumables, the cost 
of non-consumables, the cost of training, the cost of staff and the cost of waste 
management. The costs of consumables per circumcision were taken from invoices 
of ordered equipment. The duration of the procedure was applied to the salaries 
of relevant health care workers to calculate the staff costs per circumcision. The 
cost of five days training for two professional nurses and two enrolled nurses was 
included. The amount of biohazardous waste per procedure was used to estimate 
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the cost of waste. Indirect costs, such as capital costs, maintenance and utility 
costs, the cost of support personnel, and the cost of management were also 
included. The unit cost per circumcision was estimated by multiplying the amount 
of each resource used by the cost of each resource. 
 
5.3 Health Technology Assessments 
Jones and Nickerson (1986) (49) examined the costs of the Early and Periodic 
Screening, Diagnosis, and Treatment program in Maine in the USA. Thirteen 
community based agencies contacted and enrolled children of families that were 
new and re-eligible for Medicare. The sum of the number of families informed, the 
number of children due for screening and the number of children for whom 
screening had been requested was defined as each agency’s workload. Due to poor 
record keeping on the part of the agencies, the exact costs of informing families 
about the program could not be isolated. Therefore, the total amount billed to the 
state by each agency was taken as the cost. The state wide unit cost was estimated 
using a top-down approach, by dividing the total cost of all agencies by the 
combined workload of all agencies workload. This unit cost was multiplied by the 
total number of families to give the total cost of informing. The total cost of 
informing was divided by the total number of families, less those who were 
transferred or who lost their Medicare eligibility to estimate the unit cost of 
informing new or re-eligible families. 
 
Graziosi et al. (2005) (47) conducted an economic evaluation of misoprostol in the 
treatment of early pregnancy failure compared to curettage after an expectant 
management. The costs were calculated using a bottom-up approach. Resource 
use by each patient was recorded. Resources used included visits to the outpatient 
clinic, number of ultrasound scans, misoprostol usage, need for curettage, days of 
day care, days of hospital admittance, visits to general practitioner or midwives 
related to early pregnancy failure, and the treatment of complications. The unit 
costs of staff, materials, equipment, housing and overheads associated with each 
used resource were calculated. The unit cost of treatment for each patient was 
estimated by multiplying the number of each resource used by the unit cost of each 
resource. 
 
Brown et al. (2002) (46) conducted a cost effectiveness analysis of an antiplatelet 
drug (eptifibatide) in acute coronary syndromes. The cost of three procedures 
were estimated as part of this analysis, though not every study participant 
underwent a procedure. These procedures were a coronary arteriogram, a 
percutaneous coronary intervention and a coronary artery bypass graft. The costs 
of these procedures were estimated using a bottom-up approach. For example, the 
25 
 
cost of a percutaneous coronary intervention included time in the catheter 
laboratory using the laboratory overheads, the time and number of nurses and 
physicians involved, the per-use cost of the equipment and the cost of disposable 
supplies and drugs. The costs of staying in hospital also had to be estimated. These 
cost included hotel costs, such as utilities, laundry, kitchen services and 
maintenance, and overhead costs, such as general nursing and pharmacy 
overheads. The long-term costs of managing patients who had a disabling stroke 
was approximated using the cost of nursing home care. The average rate of 
procedures, diagnostic tests, dose of medications, length of stay in a hospital bed 
per patient were multiplied by the appropriate cost to estimate the unit cost per 
patient of each treatment arm of the study. 
 
Griebsch et al. (2006) (45) investigated the cost effectiveness of screening with 
contrast enhanced MRI versus screening with mammography for women with a 
high familial risk of breast cancer in the UK. Data were collected on staff levels, 
consumables, equipment, maintenance costs, capital costs and overheads. The 
cost of the contrast material was based on the woman’s weight. Information on 
the amount of time associated with screening and diagnosing patients was applied 
to the midpoint of the salary scale (plus national insurance and employer’s 
contribution to pension) of each relevant member of staff to calculate the cost of 
staff. Due to specific requirements of the clinical research protocol, some 
equipment, consumable and staff costs were adjusted. The cost of the contrast 
material was reduced due to the introduction of a generic. Staff time needed was 
reduced due to greater familiarity with the process. The cost of MRI equipment 
was reduced to more closely reflect clinical MRI machines than high specification 
MRI machines used in research. These unit costs of resources were attached to the 
resource utilisation of the different treatment arms to estimate the unit cost per 
patient of each treatment arm. 
 
Sculpher et al. (2002) (48) undertook a cost analysis of coronary angioplasty versus 
medical therapy for angina in England. Information on resource use and cost was 
mainly sourced from five regional referral centres (two in London, one in the 
midlands and two in the north of England. Centre specific unit costs for a coronary 
arteriogram, percutaneous transluminal coronary angioplasty and coronary artery 
bypass graft were estimated. These estimates incorporated the costs of medical 
and nursing staff, procedure related drugs and anaesthetics, equipment, 
consumables and an allocation of relevant overheads. Each of the five centres also 
provided the allocation costs of some medical equipment. Ward costs were 
excluded from the procedure costs and estimate separately. Ward costs included 
the costs of medical and nursing staff, equipment, consumables and an allocation 
of relevant overheads. The unit cost of the procedures and ward costs was an 
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average across the five centres. The unit costs of GP visits, inpatient wards, district 
nurse visits and pharmaceutical prices were sourced from the literature. 
 
Mujica Mota et al. (2006) (50) evaluated the costs of out of home day care for 
families living in a disadvantaged area of London. The costs of centre-based care 
were calculated using a bottom-up approach with one exception. The unit cost of 
private nurseries was estimated through a telephone survey of 20 providers. The 
unit cost of day nurseries were derived for three different age cohorts of children 
between the ages of six months and five years. Unit costs for other childcare 
services were derived from information about local childminders and playgroups. 
Unit costs of council funded playgroups were estimated by dividing total 
expenditure by the number of child sessions per year. The unit costs of health and 
social care services were sourced from the literature. The cost of travel to seek 
health care was assumed to be twice the typical cost for a London journey. The unit 
costs of each resource were multiplied by resource utilisation to estimate the unit 
cost of out of home day care per mother. 
 
6 Summary and conclusion 
Irish studies included in this review that calculated unit costs fell into the 
disease/setting specific category or the health technology assessment category. 
Most of these studies used a bottom-up or a mixture of a bottom-up and top-down 
approaches. These studies made use of existing repositories of costs, such as HIPE 
and the MIMS Ireland catalogue, where possible and engaged in the estimation of 
unit costs where practical. The data necessary to calculate unit costs, especially 
from private providers, are not always available to researchers. Similarly, data 
necessary to calculate unit costs are not always routinely collected in a form that 
is accessible to researchers.  
 
PSSRU unit costs and unit cost methodologies are heavily cited, particularly in the 
UK. Indeed, there is some evidence of PSSRU unit costs being used in an Irish 
context (19) and of PSSRU methods being adapted to an Irish setting (17). Evidence 
of another comparably referenced research unit or institute in Ireland, the UK or 
further afield was not found in the course of this review. A higher proportion of 
studies reviewed used a bottom-up approach to estimate unit costs or sourced unit 
costs that had been estimated using a bottom-up approach. Bottom-up 
approaches dominated when there may have been a greater need for precision in 
estimates, such as in health technology assessments, or when the extra data 
requirements of the bottom-up approach were not as penalising, such as with 
disease/setting specific studies. In contrast, the proportion of studies that opted 
to use a top-down approach was higher among studies that needed to estimate 
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unit costs across a wide range of services and diseases, that is, non-disease specific 
studies and health and social care projection models. This may have been due to 
the increasing penalty of larger data requirements, and so research time, skills and 
funds, associated with using a bottom-up approach across a broad spectrum of 
services. 
 
At present, the Irish system suffers from lack of a centralised unit, like the PSSRU 
in England, tasked with producing annual volumes of unit costs for health and 
social care. The development of comprehensive unit cost profiles for Irish health 
and social care services would be of significant benefit to researchers, 
policymakers and wider health system stakeholders.
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Appendix 
Table A1: Approach used, useful life of equipment specified, discount rate used for the cost of equipment and the use of direct care and supportive cost centres by study 
type. 
 
Study Type 
Approach Useful Life of Equipment Equipment Discount Rate 
Cost Centres Used a 
Bottom-up Mixed Top-down 5 years 10 years Other 3% 3.5% 5% Other 
Projection Models - 1 3 - - 1b - - - - - 
Irish 
Disease/Setting Specific 4 1 1 2 1 - - 1 1 1c - 
Health Technology 
Assessment 
- 1 - - - - - - - - - 
Guideline 1 - - - - - - - 1 - - 
Total (Irish) 5 2 1 2 1 - - 1 2 1 - 
International 
Non-Disease Specific 7 2 4 1 - - 2 1 - - 4 
Disease/Setting Specific 8 5 - 1 2 1d 1 - - 1e 4 
Health Technology 
Assessment 
4 1 1 - - - - 1 - - - 
Total (International) 19 8 5 2 2 1 3 2 - 1 - 
Notes a The study used direct care and support cost centres, with support centre costs being allocated to direct care centres according to a decision rule 
 b Equipment has a useful life of 8 years 
 c Equipment is discounted at a rate of 4 per cent 
 d Equipment has a useful life of between 2 and 5 years 
 e Equipment is discounted at a rate of 6 per cent 
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Table A2: Useful life of equipment specified, discount rate used for the cost of equipment and the use of direct care and supportive cost centres by study approach. 
 
Study Approach Number 
Equipment Lifespan Equipment Discount Rate 
Cost centres used a 
5 years 10 years Other 3% 3.5% 5% Other 
Bottom-up 24 3 2 1b 1 2 2 2c - 
Mixed 13 1 1 - 1 1 - - 5 
Top-down 9 - 1 1d 1 - - - 3 
Notes a The study used direct care and support cost centres, with support centre costs being allocated to direct care centres according to a decision rule 
 b Equipment has a useful life of between 2 and 5 years 
 c Equipment is discounted at a rate of 4 and 6 per cent respectively in each study 
 d Equipment has a useful life of 8 years 
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